1. Home
  2. OCGN vs NWFL Comparison

OCGN vs NWFL Comparison

Compare OCGN & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • NWFL
  • Stock Information
  • Founded
  • OCGN 2013
  • NWFL 1870
  • Country
  • OCGN United States
  • NWFL United States
  • Employees
  • OCGN N/A
  • NWFL N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • NWFL Major Banks
  • Sector
  • OCGN Health Care
  • NWFL Finance
  • Exchange
  • OCGN Nasdaq
  • NWFL Nasdaq
  • Market Cap
  • OCGN 283.3M
  • NWFL 228.7M
  • IPO Year
  • OCGN N/A
  • NWFL 1998
  • Fundamental
  • Price
  • OCGN $1.05
  • NWFL $25.03
  • Analyst Decision
  • OCGN Strong Buy
  • NWFL Buy
  • Analyst Count
  • OCGN 3
  • NWFL 3
  • Target Price
  • OCGN $6.00
  • NWFL $28.50
  • AVG Volume (30 Days)
  • OCGN 2.6M
  • NWFL 17.2K
  • Earning Date
  • OCGN 08-01-2025
  • NWFL 07-22-2025
  • Dividend Yield
  • OCGN N/A
  • NWFL 4.91%
  • EPS Growth
  • OCGN N/A
  • NWFL N/A
  • EPS
  • OCGN N/A
  • NWFL 0.37
  • Revenue
  • OCGN $4,754,000.00
  • NWFL $53,958,000.00
  • Revenue This Year
  • OCGN N/A
  • NWFL $79.89
  • Revenue Next Year
  • OCGN N/A
  • NWFL $7.62
  • P/E Ratio
  • OCGN N/A
  • NWFL $69.04
  • Revenue Growth
  • OCGN N/A
  • NWFL N/A
  • 52 Week Low
  • OCGN $0.52
  • NWFL $21.25
  • 52 Week High
  • OCGN $1.40
  • NWFL $34.50
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 53.85
  • NWFL 54.01
  • Support Level
  • OCGN $1.01
  • NWFL $24.80
  • Resistance Level
  • OCGN $1.07
  • NWFL $25.44
  • Average True Range (ATR)
  • OCGN 0.05
  • NWFL 0.60
  • MACD
  • OCGN 0.00
  • NWFL 0.16
  • Stochastic Oscillator
  • OCGN 66.48
  • NWFL 76.44

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

Share on Social Networks: